ICD-11 (psychiatric section): who diagnoses better treats better?

Vladimir D. Mendelevich

Neurology Bulletin ›› 2022, Vol. LIV ›› Issue (3) : 5 -10.

PDF (2625KB)
Neurology Bulletin ›› 2022, Vol. LIV ›› Issue (3) :5 -10. DOI: 10.17816/nb108994
Editorial
review-article

ICD-11 (psychiatric section): who diagnoses better treats better?

Author information +
History +
PDF (2625KB)

Abstract

The article analyzes the reasons for the opposition of a significant number of Russian psychiatrists to the introduction of a new international classification of mental and behavioral disorders (ICD-11). An opinion is expressed that the increase in the effectiveness of therapy from ICD-9 to ICD-10 in world psychiatry is associated not so much with the transition to syndromic (anosological) assessment of clinical phenomena, but because of the widespread use of modern psychopharmacological drugs and the introduction of evidence-based medicine principles, which in domestic psychiatry are also criticized. It is argued that two important aspects of psychiatry — diagnosis and therapy — are practically independent of each other, and the entire dispute about rejection or acceptance of the new classification (ICD-11) has nothing to do with the effectiveness of therapy.

Keywords

ICD-11 / psychiatric diagnostics / psychopharmacotherapy / evidence-based medicine

Cite this article

Download citation ▾
Vladimir D. Mendelevich. ICD-11 (psychiatric section): who diagnoses better treats better?. Neurology Bulletin, 2022, LIV(3): 5-10 DOI:10.17816/nb108994

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ICD-11. International Classification of Diseases 11th Revision. https://icd.who.int/en (access date: 25.06.2022).

[2]

Makushkin EV, Oskolkova SN, Fastovcev GA. Psihiatriya budushchego: mnogoaspektnost’ problem sovremennoj psihiatrii i razrabotka novyh klassifikacionnyh sistem. Zhurnal nevrologii i psihiatrii. 2017;8:118–123. DOI: 10.17116/jnevro201711781118-123. (In Russ.)

[3]

Макушкин Е.В., Осколкова С.Н., Фастовцев Г.А. Психиатрия будущего: многоаспектность проблем современной психиатрии и разработка новых классификационных систем // Журнал неврологии и психиатрии. 2017. №8. С. 118–123. DOI: 10.17116/jnevro201711781118-123.

[4]

D’yachenko AV, Soldatkin VA, Buhanovskaya OA, Perekhov AYa. Rasstrojstva polovoj identifikacii u detej i podrostkov v psihiatricheskoj praktike. Social’naya i klinicheskaya psihiatriya. 2021;2:69–78. (In Russ.)

[5]

Дьяченко А.В., Солдаткин В.А., Бухановская О.А., Перехов А.Я. Расстройства половой идентификации у детей и подростков в психиатрической практике // Социальная и клиническая психиатрия. 2021. №2. С. 69–78.

[6]

Western D. Prototype diagnosis of psychiatric syndromes. World Psychiatry. 2012;11(1):16–21. DOI: 10.1016/j.wpsyc.2012.01.004.

[7]

Western D. Prototype diagnosis of psychiatric syndromes // World Psychiatry. 2012. Vol. 11. N. 1. Р. 16–21. DOI: 10.1016/j.wpsyc.2012.01.004.

[8]

Krasnov VN. ICD-11 as a paradigm shift phase in the classification of mental disorders. Consortium Psychiatricum. 2021;2(2):72–75. DOI: 10.17816/CP70.

[9]

Krasnov V.N. ICD-11 as a paradigm shift phase in the classification of mental disorders // Consortium Psychiatricum. 2021. Vol. 2. N. 2. Р. 72–75. DOI: 10.17816/CP70.

[10]

Rid DzhM, Krasnov VN, Kulygina MA. Podgotovka MKB-11: osnovnye zadachi, principy i etapy peresmotra klassifikacii psihicheskih i povedencheskih rasstroĭstv. Social’naya i kli-nicheskaya psihiatriya. 2013;23(4):56–61. (In Russ.)

[11]

Рид Дж.М., Краснов В.Н., Кулыгина М.А. Подготовка МКБ-11: основные задачи, принципы и этапы пересмотра классификации психических и поведенческих расстройств // Социальная и клиническая психиатрия. 2013. Т. 23. №4. С. 56–61.

[12]

Rebello TJ, Kulygina MA, Krasnov VN et al. Engagement of Russian mental health professionals in the development of WHO’s ICD-11. Consortium Psychiatricum. 2021;2(2):17–21. DOI: 10.17816/CP79.

[13]

Rebello T.J., Kulygina M.A., Krasnov V.N. et al. Engagement of Russian mental health professionals in the development of WHO’s ICD-11 // Consortium Psychiatricum. 2021. Vol. 2. N. 2. P. 17–21. DOI: 10.17816/CP79.

[14]

Kulygina MA, Syunyakov TS, Fedotov IA, Kostyuk GP. Toward ICD-11 implementation: Attitudes and expectations of the Russian Psychiatric Community. Consortium Psychiatricum. 2021;2(2):23–34. DOI: 10.17816/CP80.

[15]

Kulygina M.A., Syunyakov T.S., Fedotov I.A., Kostyuk G.P. Toward ICD-11 implementation: Attitudes and expectations of the Russian Psychiatric Community // Consortium Psychiatricum. 2021. Т. 2. №2. С. 23–34. DOI: 10.17816/CP80.

[16]

Cygankov BD, Ovsyannikov SA. O celesoobraznosti perekhoda k nacional’noj klassifikacii psihicheskih zabolevanij dlya ispol’zovaniya v pedagogicheskoj rabote i pri provedenii nauchnyh issledovanij (proekt). Psihiatriya i psihofarmakoterapiya. 2011;2:8–9. (In Russ.)

[17]

Цыганков Б.Д., Овсянников С.А. О целесообразности перехода к национальной классификации психических заболеваний для использования в педагогической работе и при проведении научных исследований (проект) // Психиатрия и психофармакотерапия. 2011. №2. С. 8–9.

[18]

Ostroglazov VG. O proekte nacional’noj klassifikacii psihicheskih boleznej BD Cygankova — SA Ovsyannikova. Psihiatriya i psihofarmakoterapiya. 2012;2:61–66. (In Russ.)

[19]

Остроглазов В.Г. О проекте национальной классификации психических болезней Б.Д. Цыганкова — С.А. Овсянникова // Психиатрия и психофармакотерапия. 2012. №2. С. 61–66.

[20]

Türkçapar MH. How will DSM 5 and ICD-11 affect the treatment guidelines? Bulletin of Clinical Psychopharmacology. 2012;22(1):5.

[21]

Türkçapar M.H. How will DSM 5 and ICD-11 affect the treatment guidelines? // Bulletin of Clinical Psychopharmacology. 2012. Vol. 22. N. 1. P. 5.

[22]

Mendelevich VD, Pyrkova KV. Psihofarmakoterapiya zdorovyh i problema off-label v sovremennoj psihiatrii. Nevrologicheskij vestnik. 2020;1:5–8. DOI: 10.17816/nb19090. (In Russ.)

[23]

Менделевич В.Д., Пыркова К.В. Психофармакотерапия здоровых и проблема off-label в современной психиатрии // Неврологический вестник. 2020. №1. С. 5–8. DOI: 10.17816/nb19090.

[24]

Yu Yu, Zhou W, Shen M et al. Clinical and personal recovery for people with schizophrenia in China: Prevalence and predictors. J Ment Health. 2022;31(2):263–272. DOI: 10.1080/09638237.2021.2022635.

[25]

Yu Yu., Zhou W., Shen M. et al. Clinical and personal recovery for people with schizophrenia in China: prevalence and predictors // J. Ment. Health. 2022. Vol. 31. N. 2. Р. 263–272. DOI: 10.1080/09638237.2021.2022635.

[26]

Liberman RB. Recovery from schizophrenia: form follows functioning. World Psychiatry. 2012;11(3):161–162. DOI: 10.1002/j.2051-5545.2012.tb00118.x.

[27]

Liberman R.B. Recovery from schizophrenia: form follows functioning // World psychiatry. 2012. Vol. 11. N. 3. P. 161–162. DOI: 10.1002/j.2051-5545.2012.tb00118.x.

[28]

Mendelevich VD. Chto daet pacientu psihiatricheskij diagnoz i obosnovan li trend na uvelichenie chisla boleznej? Nevrologicheskij vestnik. 2019;1:52–54. DOI: 10.17816/nb13560. (In Russ.)

[29]

Менделевич В.Д. Что даёт пациенту психиатрический диагноз и обоснован ли тренд на увеличение числа болезней? // Неврологический вестник. 2019. №1. С. 52–54. DOI: 10.17816/nb13560.

[30]

Potapov IV, Kuzin YuA. O konferencii «Mezhdunarodnaya klassifikaciya psihicheskih rasstrojstv: ot MKB-10 k MKB-11». Psihiatriya i psihofarmakoterapiya. 2014;2:69–70. (In Russ.)

[31]

Потапов И.В., Кузин Ю.А. О конференции «Международная классификация психических расстройств: от МКБ-10 к МКБ-11» // Психиатрия и психофармакотерапия. 2014. №2. С. 69–70.

[32]

Mendelevich VD. Dokazatel’naya psihoterapiya: mezhdu vozmozhnym i neobhodimym. Nevrologicheskij vestnik. 2019;(2):4–11. DOI: 10.17816/nb15656. (In Russ.)

[33]

Менделевич В.Д. Доказательная психотерапия: между возможным и необходимым // Неврологический вестник. 2019. №2. С. 4–11. DOI: 10.17816/nb15656.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF (2625KB)

160

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/